Last reviewed · How we verify
NCT03856476
The Effect of Childhood Dyslipidemia on Endothelial and Renal Function
trial in Dyslipidemias in 200 participants. Completed in 3 April 2020.
3 April 2020
Quick facts
| Lead sponsor | University of Ioannina |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 3 April 2017 |
| Primary completion | 3 April 2020 |
| Estimated completion | 3 April 2020 |
| Sites | 1 location across Greece |
Conditions studied
- Dyslipidemias — all drugs for Dyslipidemias →
- Children, Only — all drugs for Children, Only →
- Endothelial Dysfunction — all drugs for Endothelial Dysfunction →
- Renal Dysfunction — all drugs for Renal Dysfunction →
Sponsor
University of Ioannina
Who can join
Adults 7 to 17, any sex, with Dyslipidemias or Children, Only. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to assess if abnormal lipid levels in childhood could cause early damage of the inner layer of the vessels, the endothelium. Dysfunction of the endothelium is the first event in the development of atherosclerosis, is present at all stages of atherosclerosis and is potentially reversible in childhood. It has been suggested that dyslipidemia, via its detrimental effects on endothelium, could impair renal function. This study will assess the dysfunction of the kidneys in children with dyslipidemia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03856476
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dyslipidemias
Currently open trials in the same condition.
- NCT07308314 — Taining Golden Lake Comprehensive Chronic Disease Management Initiative · recruiting
- NCT06526273 — PILI 'Āina Household · NA · recruiting
- NCT06797401 — Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia · Phase 2 · recruiting
- NCT06380322 — Military Health and Nutrition Examination Study · recruiting
- NCT06183307 — Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia · NA · recruiting
Other University of Ioannina trials
Trials by the same sponsor.
- NCT07048522 — Perioperative Intravenous Nimodipine Trial · NA · recruiting
- NCT06961825 — Brief Title: The Role of Nutrition in the Rehabilitation of Patients With Eating Disorders After a Vascular Stroke. · NA · not yet recruiting
- NCT06758518 — Study of the Carpal Tunnel Syndrome in Relation to Stress and Depression Among Medical Students · enrolling by invitation
- NCT07164300 — Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery · NA · recruiting
- NCT07023497 — Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03856476 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Ioannina
- Last refreshed: 3 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03856476.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing